A number of therapeutic proteins are used for long in clinical practice. These include for example insulin, calcitonine, growth hormone, and parathyroid hormone for the treatment of various systemic disorders, as well as protein antigens in vaccine formulations. Due to the recent developments in biochemical engineering and in the comprehension of the physiopathology of many diseases, peptides and proteins are expected to become a drug class of increasing importance. Recently, novel biological drugs have for example been developed such as monoclonal antibodies, antibody fragments, soluble receptors, and receptor agonists or antagonists. These are mainly used for the treatment of auto-immune and inflammatory diseases (asthma, rheumatoid arthritis) and for the treatment of cancers. However, a major drawback of these biomolecules is the need to use parenteral administration. This is mainly due to the harsh pH conditions that proteins undergo by oral administration, leading to various physico-chemical degradations and loss of biological activity. <p><p>Pulmonary delivery of these proteins could constitute an alternative to parenteral delivery. Due to the very high surface area of the lungs, the low thickness of the alveolar epithelium and the high level of lung vascularisation, pulmonary administration can indeed provide fast systemic absorption of drugs, while avoiding hepatic first pass metabolism. On the other hand, drugs for local treatment can also be administered directly into the lung, which allows delivering high doses while limiting systemic side effects. Nevertheless, administration of drugs to the lungs requires some challenges to be taken up. It is indeed necessary to provide the drug as very small solid or liquid microparticles (1-5 µm) in order to reach the lungs. For solid microparticles, it is also needed to overcome the very high inter-particle interactions by using appropriate formulation strategies and by including deaggregation mechanisms in the inhalation device. Other issues are more specifically related to the pulmonary administration of proteins. These can indeed undergo physico-chemical degradations during processing, administration, and/or storage. Moreover, if systemic action is required, proteins will often need addition of an absorption enhancer to cross the alveolar epithelium because of their large molecular weight and hydrophilicity. <p><p>In this work, we developed formulations for pulmonary delivery of proteins using two model proteins. Insulin (5.8 kDa) was chosen as a model of small protein. It is also an application of systemic pulmonary delivery. On the other hand, an anti-IL13 monoclonal antibody fragment (54 kDa) was used as a model of larger protein. This molecule is currently in development for the treatment of asthma and provided an application for local pulmonary delivery. The formulation strategy was to produce dry powders using a combination of micronisation techniques (high speed and high pressure homogenisations), drying techniques (spray-drying, freeze-drying), and addition of lipid excipients. These lipid excipients were added as a coating around the protein particles and were expected to prevent protein degradations during processing and/or storage, essentially by avoiding contact with water. It could also improve the aerodynamic properties of the powders by modification of the surface properties of the particles and/or limitation of the capillary forces.<p><p>First, we evaluated insulin lipid-coated formulations and formulations without excipients, produced using high pressure homogenisation and spray-drying. In the case of lipid-coated formulations, a physiological lipid composition based on a mixture of cholesterol and phospholipids was used. We were able to obtain good aerodynamic features for the different formulations tested, with fine particle fractions between 46% and 63% versus 11% for raw insulin powder. These are high FPF values in comparison with those obtained for other protein formulations for inhalation currently under development, which often have an in vitro deposition of around 30%. Insulin presented a good stability in the dry state, even when no lipid coating was added.<p>The presence of a lipid coating of up to 30% (w/w) did not significantly improve the aerodynamic behaviour of the powders, but the coated formulations exhibited decreased residual moisture content after 3-month storage, which should be of interest for the long-term stability of the formulations. <p><p>In a second step, two of the developed insulin formulations were evaluated in a clinical study to determine whether the formulations give high deep lung deposition in vivo, and how insulin is absorbed into the systemic blood stream. This pharmaco-scintigraphic trial was performed on twelve type 1 diabetic patients using an uncoated formulation and a formulation coated with 20% (w/w) of lipids. The two formulations showed interesting features, with pharmacokinetic profiles that mimic the natural insulin secretion pattern. Bioavailability was within the ranges of two of the three dry powder insulins that have reached phase III clinical development. However, the formulation with a lipid coating exhibited a lower lung deposition in comparison with the uncoated formulation, which was not expected from the previous in vitro results. Additional in vitro experiments indicated that this lower performance was related to a decrease in the disaggregation efficiency of the powder at a sub-optimal inhalation flow-rate. An extensive training of the patients to the inhalation procedure could therefore improve the lung deposition of the coated formulation.<p><p>Finally, we developed and evaluated dry powder formulations of the anti-IL13 antibody fragment. These were produced using, successively, freeze-drying, high pressure homogenisation (HPH), and spray-drying. The influence of different types and concentrations of stabilising excipients was evaluated for each production step. Due to its more elaborated structure, the antibody fragment was found to be more sensitive than insulin to physico-chemical degradation, particularly during the HPH process, which led to different types of degradation products. These could partly be avoided by adding 50% sucrose during freeze-drying and 10% Na glycocholate or palmitic acid in the liquid phase during HPH (dispersing agents). However, the presence of a small fraction of insoluble aggregates could not be fully avoided. Further spray-drying of the suspensions in the presence of 10% Na glycocholate or palmitic acid led to the formation of a hydrophilic or hydrophobic coating around the particles, respectively. Na glycocholate was found to be particularly effective in protecting the antibody during spray-drying, which was found to be at least partly related to its ability to inhibit sucrose recrystallisation. However, the best formulation still presented a small fraction of insoluble aggregates (6%). The aerodynamic evaluation of the formulations showed FPFs that were compatible with lung deposition, with the formulation containing Na glycocholate presenting the highest FPF (42%). The formulation coated with palmitic acid presented a slightly lower FPF (35%). The aerodynamic properties of this formulation remained unchanged at a sub-optimal inspiratory flow rate, to the contrary of what was observed for the insulin formulation coated with 20% (w/w) cholesterol and phospholipids. Palmitic acid could therefore be of interest as a hydrophobic coating material, and provide long-term stability of protein drugs. <p>The work performed with the insulin and anti-IL13 molecules provided the proof-of-concept that it was possible to obtain dry powder protein formulations with appropriate aerodynamic properties and good overall physico-chemical stability, using simple production techniques and few selected excipients. The formulation strategy presented in this work could therefore be of interest for the future development of inhaled proteins for local or systemic applications. <p> / Doctorat en sciences pharmaceutiques / info:eu-repo/semantics/nonPublished

Изучено влияние природы растворителя и магнитного порошка на процесс кристаллизации поливинилиденфторида (ПВДФ). Методам изотермической микрокалориметрии определены энтальпии разбавления ПВДФ в растворителях различной химической природы. Полученные данные использованы для расчета параметров Флори-Хаггинса. Получены полимерные композиционные материалы на основе ПВДФ и порошков никеля и железа. Получены зависимости степени кристалличности композиций и максимумов температур плавления от состава. Изучен их фазовый состав методами инфракрасной спектроскопии и дифференциальной сканирующей калориметрии. / The influence of the nature of the solvent and magnetic powder on the crystallization process of polyvinylidenefluoride (PVDF) has been studied. The enthalpies of dilution of PVDF in solvents of various chemical nature are determined by the methods of isothermal microcalorimetry. Data used to calculate Flory-Huggins parameters. Polymer composite materials based on PVDF and powders of nickel and iron are obtained. The dependences of the degree of crystallinity of the compositions and maxima of the melting points on the composition were obtained. The phase composition was studied using infrared spectroscopy and differential scanning calorimetry.

No / With increasing interest in hot melt extrusion for preparing polymer-drug systems, knowledge of the shear and extensional rheology of polymers is required for the formulation and process design. Shear and extensional rheology of three commercial grades of hydroxypropyl cellulose (HPC) was examined at 140, 145 and 150 degrees C using twin bore capillary rheometry at range of processing rates. The power law model fitted for shear flow behaviour up to shear strain rates of approximately 1000s(-1), above which measured shear viscosities deviated from the power law and surface instabilities were observed in the extrudate, particularly for higher molecular weight grades. Shear thinning index was found to be relatively independent of temperature and molecular weight, whilst the consistency index, indicative of zero shear viscosity increased exponentially with increase in molecular weight. Extensional viscosity of all grades studied was found to decrease with increasing temperature and increasing processing rate. Foaming of the extrudate occurred especially at low temperatures and with the high molecular weight grade. An understanding of the relationships between shear and extensional flows with temperature, processing rate and molecular weight is a useful tool for process design; optimisation and troubleshooting of Hot melt extrusion (HME) of pharmaceutical formulations.

No / PURPOSE: To explore the use of crystal inter-planar d-spacings and slip-plane interaction energies for predicting and characterising mechanical properties of crystalline solids. METHODS: Potential relationships were evaluated between mechanical properties and inter-planar d-spacing, inter-planar interaction energy, and dispersive surface energy as determined using inverse gas chromatography (IGC) for a set of pharmaceutical materials. Inter-planar interaction energies were determined by molecular modelling. RESULTS: General trends were observed between mechanical properties and the largest inter-planar d-spacing, inter-planar interaction energies, and IGC dispersive surface energy. A number of materials showed significant deviations from general trends. Weak correlations and outliers were rationalised. CONCLUSIONS: Results suggest that the highest d-spacing of a material could serve as a first-order indicator for ranking mechanical behaviour of pharmaceutical powders, but with some reservation. Inter-planar interaction energy normalised for surface area shows only a weak link with mechanical properties and does not appear to capture essential physics of deformation. A novel framework linking mechanical properties of crystals to the distinct quantities, slip-plane energy barrier and inter-planar interaction (detachment) energy is proposed.

Solution combustion synthesis (SCS) with its origin at IPC department of IISc has been widely practiced for synthesis of oxide materials. It is simple and low cost process, with energy and time savings that can be used to produce homogeneous, high purity, uniformly doped, nano crystalline ceramic powders. The powders characteristics such as crystallite size and surface area are primarily governed by enthalpy, flame temperature of combustion, fuel and fuel to oxidizer ratio ( F/O). In the present work an attempt has been made to investigate the process in order to exercise a control over the phase formation and nature of the product. Initial part of the work deals with the effect of fuel to oxidizer ratio on the powder properties of binary oxides with urea as fuel. The variation of adiabatic flame temperatures are calculated theoretically for different F/O ratios according to thermodynamic concept and correlated with the observed flame temperatures. Difference in the measured flame temperature and theoretical flame temperature in the fuel rich region is explained on the basis of incomplete combustion model. The effect of decomposition temperature difference of fuel and oxidizer, solubility of reactants on exothermicity of combustion reaction taking aluminiumnitrate system for various fuels is investigated. The effect of mixed fuel approach is studied by using the urea-glycine mixed fuel system using aluminium nitrate as oxidizer and employed for successful synthesis of the gamma alumina. Further Compaction behavior of SCS nano ceramic powders is studied by using Universal testing machine and the effect of F/O ratio, on agglomeration strength, aggregation strength of powder is investigated. Very few reports can be found on usage of SCS ceramic powder for biomaterial applications. By using these investigations a pyroxene series Diopside (CaMgSi2O6) silicate material is synthesized by SCS. Effect of different fuels on Diopside (DP) phase formation is investigated. Finally the DP and DP-ZnO composites, made by using Uniaxial hot pressing are investigated for their antibacterial, cytocompatibility properties. Antibacterial activity of E.Coli bacterium of Diopside powders was dose dependent type. Results of the bioactivity investigations shown flattened MC3T3 mouse osteoblast cells and MC C2C12 Myoblast cells and linkage bridges formed between them on Diopside and DP-ZnO surfaces show cyto compatibility and MTT results showed that percentage of ZnO needs to be tailored between 0-10 in order to achieve maximum cytocompatibility coupled with antibacterial property.

The available literature indicates that to date, few research has been performed on oil powders for topical delivery. The aim of this project was to investigate the release characteristics of oil powder formulations, as well as their dermal and transdermal delivery properties. Whey protein-stabilised emulsions were used to develop oil powders. Whey protein was used alone, or in combination with chitosan or carrageenan. Nine oil powders, with salicylic acid as the active ingredient, were formulated by using the layer-by-layer method. Three different pH values (pH 4, 5 and 6) were used to prepare the formulations, because of the different charges that polymeric emulsifiers may have. The characteristics of the prepared oil powders were determined, including their droplet sizes, particle size distributions, loss on drying, encapsulation efficiencies, oil leakage and water dispersibility. Release studies (membrane diffusion studies) were conducted by utilising cellulose acetate membranes (0.2 μm pore size) and Franz-type diffusion cells over a period of eight hours. The release of the active ingredient was determined for all nine powders, their respective template emulsions, as well as their respective oil powders redispersed in water. The release of salicylic acid from the respective redispersed oil powders was then further compared to its release from the template emulsions and from the oil powders. The effect of pH and different polymer types used in preparing the oil powders, their respective redispersed oil powders and the template emulsions were determined with regards to the release of the active ingredient from all these preparations. The effect of pH and different polymers used was furthermore determined on the oil powders and their respective redispersed oil powders, with regards to their dermal and transdermal deliveries. Transdermal delivery and skin uptake were investigated on specifically selected powders only, based on the outcomes of the oil powder characterisation and release data. The qualifying formulations were chitosan pH 4, 5 and 6, whey and carrageenan pH 6 oil powders, together with their respective redispersed oil powders in water. Human abdominal skin was dermatomed (thickness 400 μm) for use in the diffusion studies. Franz-type diffusion cells were used over a period of 24 hours. The results of the membrane release studies indicated that the oil powders had achieved a significantly higher release than their respective redispersed oil powders. The release of salicylic acid from the redispersed oil powders and from their respective emulsions was similar. The transdermal delivery test outcomes showed that the effect of pH could have been influenced by the degree of ionisation, resulting in a decrease in permeation with increasing ionisation of salicylic acid, in accordance with the pH partition hypothesis. Furthermore, biopolymers, such as chitosan had demonstrated a penetration enhancing effect, which had led to the enhanced dermal and transdermal delivery of salicylic acid. A correlation was also found between the powder particle size and transdermal delivery. / MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2014

The available literature indicates that to date, few research has been performed on oil powders for topical delivery. The aim of this project was to investigate the release characteristics of oil powder formulations, as well as their dermal and transdermal delivery properties. Whey protein-stabilised emulsions were used to develop oil powders. Whey protein was used alone, or in combination with chitosan or carrageenan. Nine oil powders, with salicylic acid as the active ingredient, were formulated by using the layer-by-layer method. Three different pH values (pH 4, 5 and 6) were used to prepare the formulations, because of the different charges that polymeric emulsifiers may have. The characteristics of the prepared oil powders were determined, including their droplet sizes, particle size distributions, loss on drying, encapsulation efficiencies, oil leakage and water dispersibility. Release studies (membrane diffusion studies) were conducted by utilising cellulose acetate membranes (0.2 μm pore size) and Franz-type diffusion cells over a period of eight hours. The release of the active ingredient was determined for all nine powders, their respective template emulsions, as well as their respective oil powders redispersed in water. The release of salicylic acid from the respective redispersed oil powders was then further compared to its release from the template emulsions and from the oil powders. The effect of pH and different polymer types used in preparing the oil powders, their respective redispersed oil powders and the template emulsions were determined with regards to the release of the active ingredient from all these preparations. The effect of pH and different polymers used was furthermore determined on the oil powders and their respective redispersed oil powders, with regards to their dermal and transdermal deliveries. Transdermal delivery and skin uptake were investigated on specifically selected powders only, based on the outcomes of the oil powder characterisation and release data. The qualifying formulations were chitosan pH 4, 5 and 6, whey and carrageenan pH 6 oil powders, together with their respective redispersed oil powders in water. Human abdominal skin was dermatomed (thickness 400 μm) for use in the diffusion studies. Franz-type diffusion cells were used over a period of 24 hours. The results of the membrane release studies indicated that the oil powders had achieved a significantly higher release than their respective redispersed oil powders. The release of salicylic acid from the redispersed oil powders and from their respective emulsions was similar. The transdermal delivery test outcomes showed that the effect of pH could have been influenced by the degree of ionisation, resulting in a decrease in permeation with increasing ionisation of salicylic acid, in accordance with the pH partition hypothesis. Furthermore, biopolymers, such as chitosan had demonstrated a penetration enhancing effect, which had led to the enhanced dermal and transdermal delivery of salicylic acid. A correlation was also found between the powder particle size and transdermal delivery. / MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2014

L’objectif de ce travail est de concevoir un outil d’atomisation adapté à la production de poudres de carburede tungstène dans l’entreprise Technogenia, située à Saint-Jorioz (74). Plus généralement, nous avons étudiéune nouvelle conception d’atomiseur rotatif pour lequel les surfaces d’atomisation sont orientées selon un angled’incidence non nul. Une telle orientation permet alors d’exploiter de façon plus efficace la fréquence de rotationde l’atomiseur ainsi que les forces de centrifugation et de Coriolis. A partir de cette base de réflexion, troisgéométries de surface d’atomisation ont été étudiées : des surfaces lisses, des surfaces pourvues de structurationsde long de leur bord de fuite et des surfaces matricées de perforations.Les différents modes de déstabilisation des écoulements liquides ont été observés grâce à l’acquisition de vidéosultra-rapides des différentes étapes de l’impact d’une goutte unique sur les différentes géométries de surfacesd’atomisation étudiées. Les processus d’atomisation peuvent ainsi varier entre la rupture de jets liquides régulierscausée par des instabilités de type Rayleigh-Plateau et la rupture de nappes liquides causée par des instabilitésde type Rayleigh-Taylor et/ou l’initiation de perforations au coeur des nappes et films liquides. Les vidéos dessprays aqueux ainsi que l’observation au microscope des poudres métalliques nous permettent de caractériser lessprays produits. Sur l’ensemble de nos expériences nous observons que la finesse de l’atomisation s’améliore àmesure que la fréquence de rotation augmente ; ce qui constitue l’objectif prioritaire du procédé développé dans lathèse. Cependant, les surfaces texturées, certes compatibles avec les liquides classiques (aqueux ou organiques),ne le sont plus avec les contraintes induites par du métal à haute température de fusion, tel le carbure detungstène fondu objet de la thèse. En conséquence, seules les surfaces lisses sont aujourd’hui retenues et fontl’objet de développements dans le cadre de la production de poudres métalliques au sein de Technogenia. / The aim of this work is to design a spray tool for the production of tungsten carbide powder for the companyTechnogenia, located in Saint-Jorioz (74). Thus, we have studied a new design of rotary atomizer based onatomization surface oriented at a non-zero incidence angle. Such an orientation can then allow to use moreeffectively the rotation frequency of the atomizer and the centrifugal and Coriolis forces. From this base reflection,three geometries of atomization surface were studied : smooth surfaces, surfaces with serrated structurationsalong their trailing edge and multi-perforated surfaces.The different destabilization modes of liquid flows were observed through high-speed videos of the different stagesof the single drop impact on each atomization surfaces. The atomization process can thus vary between liquid jetbreakup caused by Rayleigh-Plateau instabilities and liquid sheet breakup caused by Rayleigh-Taylor instabilitiesand/or initiating of holes in liquid films or sheets. Videos of aqueous sprays and microscopic observation of metalpowders allow us to characterize sprays. On all of our experiments, we observe that the atomisation gets better(producing finer spray), as the frequency of rotation increases. Although the textured surfaces are compatiblewith usual liquids (aqueous or organical), they can’t stand the constraints imposed by metal with a high meltingtemperature such as tungsten carbide, the object of this thesis. Therefore, only the smooth surfaces are nowthe subject of an industrial development to produce metallic powder with Technogenia company.

Les travaux de cette thèse proposent le développement d’un procédé de fabrication de composants micro-structurés à base d’unmatériau magnétocalorique. A plus long terme, ces composants de type lame mince seront intégrés à des dispositifs deréfrigération magnétique. Leur réalisation par les procédés conventionnels tels que l’usinage n’est pas envisageable dansl’optique d’une industrialisation. La solution envisagée est basée sur la mise en forme de composants par réplication d’uncomposite magnétocalorique. Ce micro-composite est défini par le mélange des poudres magnétocaloriques hydrogénées detype La(Fe,Si)13 dans une matrice thermoplastique (PP, LDPE). Cette technique permet de bénéficier des avantages desprocédés de mise en forme des polymères comme l’extrusion ou le moulage par injection. Le développement d’un tel procédéest divisé en deux parties. La première partie concerne l’élaboration et la caractérisation du micro-compositemagnétocalorique. Les tests réalisés en mélangeur ont permis de proposer plusieurs formulations micro-compositesmagnétocaloriques selon différents taux de charge. Cette première partie du développement étudie les différents aspects dumatériau micro-composite comme la rhéologie et les propriétés magnétocaloriques des mélanges. La caractérisationrhéologique basée sur les tests au rhéomètre capillaire est réalisé afin d’évaluer la capacité de mise en forme des mélangesassociée au procédé d’extrusion-conformage. Les propriétés propres aux matériaux magnétocaloriques telles que la variationde température adiabatique (ΔT) et la température de Curie (Tc) sont investiguées. Le contrôle de la Tc par mesure DSC a misen évidence des problématiques de déshydrogénation des poudres liées à la température d’élaboration. L’impact du taux decharge en poudre est étudié par la mesure des ΔT permettant d’estimer les performances finales du micro-composite. Ladeuxième partie traite du développement du procédé de mise en forme par extrusion-conformage. Une ligne d’outillages dédiéeà l’extrusion-conformage des lames micro-structurées a été réalisée et validée à l’échelle du laboratoire. La stabilité de latempérature de Curie a été vérifiée tout au long du processus d’élaboration des composants micro-structurés. Les paramètresd’extrusion tels que la température d’extrusion ont pu être définis afin d’éviter la déshydrogénation des poudresmagnétocaloriques. Les composants extrudés sont caractérisés en termes d’homogénéité du taux de charge en poudre et detolérances géométriques aboutissant à la / This thesis proposes the development of a method of manufacturing micro-structured components made of a magnetocaloricmaterial. In the long term, these blade-type components will be integrated in magnetic refrigeration devices. On an industrialscale, their production by the conventional process, machining, is not possible. The solution proposed is based on shaping thecomponent by a replication process via a magnetocaloric composite material. This micro-composite is defined by the mixtureof hydrogenated magnetocaloric powders of La(Fe,Si)13 in a thermoplastic matrix (PP, LDPE). This technique allowsutilization of the polymer shaping process, extrusion. The development of this process is divided into two parts. The first partconcerns the development and characterization of the magnetocaloric micro-composite. Results from tests performed with themixer allow the proposal of several micro-composite formulations under different loading rates. These formulations are thenstudied for various aspects of micro-composite material. The rheological characterization based on capillary rheometer tests istaken to evaluate the shaping ability of the mixtures associated with the extrusion process. Specific properties ofmagnetocaloric materials such as the adiabatic temperature variation (ΔT) and the Curie temperature (Tc) are also investigated.The control of the Tc by DSC measurement highlighted problematic dehydrogenation of the powders as a result of theelaboration temperature. The impact of loading rate is studied by measuring the ΔT in order to estimate the final performanceof the micro-composite. The second part deals with the development of the shaping process by extrusion. A tooling linededicated to extrusion of the micro-structured blades is carried out and validated at the laboratory scale. The stability of Tc ischecked throughout the elaboration process of the micro-structured components. The extrusion parameters are defined to avoidthe dehydrogenation of magnetocaloric powders. The extruded components are characterized in terms of homogeneity of thepowder loading rate and geometric tolerances resulting in the validation of the developed process. The industrial transfer isnow possible to a large scale production.

Esse trabalho teve como objetivo verificar o efeito da adição do ácido oléico na moagem de alta velocidade/energia na obtenção de pós magnéticos em escala nanométricas da liga Pr12Fe65,9Co16B6Nb0,1. A primeira etapa deste trabalho, envolveu a obtenção de pós magnéticos por meio do processo de hidrogenação, desproporção, dessorção e recombinação (HDDR), utilizando a pressão de H2 de 930 mbar (hidrogenação e desproporção) e temperatura de dessorção e recombinação de 840 ºC. Inicialmente, os pós HDDR foram submetidos à moagem de alta velocidade/energia a 900 rpm, com variação do volume do meio de moagem (ciclohexano) sem adição de ácido oleico. Em seguida, os pós HDDR foram submetidos à moagem com adição de ácido oleico, variando o tempo de moagem. Após a moagem, foi realizado tratamento térmico dos pós a 700 ºC ou 800 ºC durante 30 min., com a finalidade de cristalização do pó. Foi verificado que, a utilização de 6,6 ml de ciclohexano como meio de moagem e com adição de ácido oleico há uma melhora na eficiência da moagem dos pós. Para adições de surfactante, de 0,02 a 0,05 ml e tempos de moagem até 360 minutos, não ocorre a aglomeração dos pós magnéticos no pote de moagem, obtendo acima de 90% de eficiência na moagem. A segunda etapa deste trabalho envolveu a caracterização dos pós magnéticos: utilizando magnetômetro de amostra vibrante, microscopia eletrônica de Varredura, microscopia eletrônica de transmissão e difração de raios-X. Os resultados obtidos mostraram que a adição de ácido oléico na moagem de alta velocidade/energia proporciona uma melhora nas propriedades magnéticas. Com a variação do tempo de moagem a fase Fe-&alpha; presente no pó HDDR apresenta diminuição no tamanho do cristalito (de 35 para ~ 10 nm) enquanto que, na fase Pr2Fe14B verifica-se menor grau de cristalinidade. / This work verified the effect caused by adding the surfactant in the high speed/energy milling in order to obtain Pr12Fe65.9Co16B6Nb0.1 magnetic nanopowders. The first part of this work involved the magnetic powder obtainment through the process of hydrogenation, disproportionation, desorption and recombination (HDDR). The pressure of H2 during the hydrogenation and disproportion steps was 930 mbar and the temperature of desorption and recombination was 840 ºC. Initially, the HDDR powders were subjected a highspeed milling process at 900 rpm, with quantity variations of the milling medium (cyclohexane) and without the addition of oleic acid. Then, the HDDR powders were subjected to the milling process with the addition of oleic acid and with milling time variations. After the milling process, heat treatments of the powder were carried out at 700 °C or 800 °C for 30 minutes in order to obtain the crystallization of the powder. By performing the procedures, it was verified that the milling efficiency improved with the addition of 6.6 ml of cyclohexane as the milling medium and with the addition of oleic acid. It was determined that for the surfactant additions of 0.02 ml to 0.05 ml, with a milling time of up to 360 minutes, powder agglomeration does not occur in the milling pot and the milling efficiency is higher than 90%. The second stage of this work involved the magnetic powders characterization obtained by using vibrating sample magnetometer, scanning electron microscopy, transmission electron microscopy and X-ray diffraction. Through the characterizations it was found that the powders magnetic properties improved when the addition of oleic acid in a high-speed /energy milling occurred. It was also verified that the &alpha;-Fe phase, present in the powder, shows a crystallite size decrease (from 35 nm to ~ 10 nm) when the time milling variation occurred; meanwhile, the crystallinity degree was lower in the Pr2Fe14B phase when the time milling variations was carried out.